IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. 1986

A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni

Cellular immunity against Salmonella typhi was observed by using a direct anti-bacterial in vitro assay in volunteers orally vaccinated with the live S. typhi mutant strain Ty 21a. With this experimental approach, it was demonstrated that Ty 21a vaccine also induces cellular immunity against S. paratyphi A and B. Interestingly, the mechanism involved in cellular immunity against bacteria seems to be of an antibody-dependent cellular cytotoxicity (ADCC) type, with IgA acting as the humoral arm and CD4+ T lymphocytes as the cellular one. In accordance with the increase in IgA-driven ADCC against S. typhi, a major rise in IgA against O and H antigens was observed in the serum of vaccinees in parallel to an increase in IgG of identical specificity. Furthermore, a Ty 21 vaccine induced cellular activity against flagellar antigens. These results indicate that IgA-ADCC by T lymphocytes against bacteria can originate from local stimulation of the gut mucosal immune system. This cellular defense mechanism might be at the origin of the protection induced by Ty 21a vaccine.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D001433 Bacteriolysis Rupture of bacterial cells due to mechanical force, chemical action, or the lytic growth of BACTERIOPHAGES. Bacteriolyses

Related Publications

A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
November 1993, The Journal of the Association of Physicians of India,
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
July 1992, The Journal of the Association of Physicians of India,
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
September 1990, Lancet (London, England),
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
April 1983, Lancet (London, England),
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
April 1988, Schweizerische medizinische Wochenschrift,
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
June 1985, European journal of clinical microbiology,
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
September 1984, Bollettino dell'Istituto sieroterapico milanese,
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
January 1983, Developments in biological standardization,
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
March 1982, The Journal of infectious diseases,
A Tagliabue, and L Villa, and M T De Magistris, and M Romano, and S Silvestri, and D Boraschi, and L Nencioni
December 1982, Acta virologica,
Copied contents to your clipboard!